Does dapsone-mediated activation of flurbiprofen metabolism by CYP2C9 occur in vivo?

被引：0
|
作者：
Hutzler, JM
Frye, RF
Korzekwa, KR
Branch, RA
Huang, SM
Tracy, TS
机构：
[1] US FDA, Rockville, MD 20857 USA
[2] Univ Pittsburgh, Ctr Clin Pharmacol, Pittsburgh, PA USA
[3] W Virginia Univ, Sch Pharm, Morgantown, WV 26506 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2000年 / 67卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII78
引用
收藏
页码：134 / 134
页数：1
相关论文
共 50 条
  • [1] Minimal in vivo activation of CYP2C9-mediated flurbiprofen metabolism by dapsone
    Hutzler, JM
    Frye, RF
    Korzekwa, KR
    Branch, RA
    Huang, SM
    Tracy, TS
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 14 (01) : 47 - 52
  • [2] Dapsone activation of flurbiprofen and naproxen metabolism in CYP2C9*1 and CYP2C9*5 variants.
    Hummel, MA
    Rettie, AE
    Dickmann, LJ
    Tracy, TS
    FASEB JOURNAL, 2002, 16 (04): : A563 - A563
  • [3] Metabolism of dapsone by CYP2C9 and its effect on CYP2C9 substrates.
    Tracy, TS
    Metz, CA
    Korzekwa, KR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 152 - 152
  • [4] Differential activation of CYP2C9 variants by dapsone
    Hummel, MA
    Dickmann, LJ
    Rettie, AE
    Haining, RL
    Tracy, TS
    BIOCHEMICAL PHARMACOLOGY, 2004, 67 (10) : 1831 - 1841
  • [5] Activation of CYP2C9 by dapsone and analogs.
    Tracy, TS
    Metz, CA
    Korzekawa, KR
    Rettie, AE
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 152 - 152
  • [6] Effect of CYP2C9 genetic polymorphism on the metabolism of flurbiprofen in vitro
    Wang, Li
    Bao, Shi-Hui
    Pan, Pei-Pei
    Xia, Meng-Ming
    Chen, Meng-Chun
    Liang, Bing-Qing
    Dai, Da-Peng
    Cai, Jian-Ping
    Hu, Guo-Xin
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2015, 41 (08) : 1363 - 1367
  • [7] Flurbiprofen as a selective in vivo probe of CYP2C9 activity.
    Frye, RF
    Tracy, TS
    Hutzler, JM
    Korzekwa, KR
    Cannon, Y
    Pauli, M
    Huang, SM
    Branch, RA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 109 - 109
  • [8] FLURBIPROFEN 4'-HYDROXYLATION BY CYP2C9
    TRACY, TS
    ROSENBLUTH, BW
    WRIGHTON, SA
    GONZALEZ, FJ
    KORZEKWA, KR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 152 - 152
  • [9] Distance dependence of flurbiprofen and dapsone in the CYP2C9 active site as studied by molecular dynamics
    Aguilar, Jarrett S.
    Hartman, Zachary R.
    Niehaus, Angela G.
    Gannett, Peter M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [10] Evaluation of flurbiprofen urinary ratios as in vivo indices for CYP2C9 activity
    Zgheib, N. K.
    Frye, R. F.
    Tracy, T. S.
    Romkes, M.
    Branch, R. A.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (04) : 477 - 487
12345